Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
3129243
Reference Type
Journal Article
Title
Vitiligo in Children: A Distinct Subset
Author(s)
Habib, A
Year
2016
Volume
26
Issue
3
Page Numbers
173-176
Language
English
PMID
26975945
DOI
03.2016/JCPSP.173176
Abstract
OBJECTIVE:
To determine clinical profile of vitiligo in children.
STUDY DESIGN:
Adescriptive study.
PLACE AND DURATION OF STUDY:
Combined Military Hospital, Abbottabad, from January 2010 to June 2013.
METHODOLOGY:
All new patients below the age of 15 years, clinically diagnosed to have vitiligo, were included in the study. A detailed history was obtained, thorough physical examination was performed, and findings were recorded on a specially designed proforma for each patient separately. Computer programme SPSS-14 was used to manage and analyze the data.
RESULTS:
Out of 157 children, 68 (43.3%) were males and 89 (56.7%) were females. Mean age at onset was 6.55 ±3.43 years. The disease started before 10 years of age in 123 (78.3%) children. Average duration of the disease was 1.48 ±1.87 years. Average duration of the disease was 1.73 ±2.09 years in male children and 1.29 ±1.67 years in female children. Generalized vitiligo was the commonest type (n = 83, 52.9%). The disease started most commonly from head and neck (n = 75, 47.8%). A family history of vitiligo was found in forty-nine (31.2%) children, Koebner phenomenon in 39 (24.8%) children and associated autoimmune or endocrine diseases in 8 (5.1%) patients.
CONCLUSION:
Majority of the children developed the disease before 10 years of age. Generalized vitiligo was the commonest type. Childhood vitiligo was more common in female children.
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity